Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material - PubMed (original) (raw)
. 2009 May;87(5):1787-93.
doi: 10.2527/jas.2008-1492. Epub 2008 Dec 19.
Affiliations
- PMID: 19098230
- DOI: 10.2527/jas.2008-1492
Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material
R G L Murphy et al. J Anim Sci. 2009 May.
Abstract
Prion diseases such as bovine spongiform encephalopathy, chronic wasting disease, and scrapie pose serious risks to human and animal health due to a host of disease-specific factors, including the resistance of infectious prions (PrP(Sc)) to natural degradation and to most commercial inactivation procedures. In an attempt to address this concern, a mouse model was used to compare the efficacy of an alkaline hydrolysis process with a simulated continuous-flow rendering treatment for disposal of PrP(Sc)-infected biological material. Female C57/BL6 mice (N = 120) were randomly divided into 4 treatment groups (n = 30), and each mouse was injected intraperitoneally with their designated treatment inoculum. Treatment groups 1 and 2 served as the positive and negative controls, respectively. Group 3 was inoculated with rendered scrapie-positive mouse brain material to investigate the effectiveness of simulated continuous-flow rendering practices to reduce or eliminate PrP(Sc). Group 4 was inoculated with hydrolyzed scrapie-positive mouse brain material to determine the sterilizing effect of alkaline hydrolysis on PrP(Sc). Mice were monitored for overt signs of disease, and those showing clinical signs were killed to prevent undue suffering. Brains were obtained from all mice that died (or were killed) and analyzed with an ELISA for the presence of PrP(Sc). Results indicated that the simulated continuous-flow rendering treatment used for preparing the rendering treatment group inoculum failed to completely eliminate PrP(Sc). Rendering delayed, but did not stop, clinical mouse-adapted scrapie transmission. Compared with positive controls, the rendering treatment group experienced an approximate 45-d average delay in days to death (250 vs. 205 d for positive controls; P < 0.0001) and a death loss of 73.9% (P = 0.0094). Positive controls suffered 100% death loss. The results validated the efficacy of the alkaline hydrolysis treatment to inactivate all PrP(Sc) because no alkaline hydrolysis treatment group mice succumbed to the disease (P < 0.0001). Based on our results, alkaline hydrolysis should be considered by the animal rendering and beef packing industries as an alternative to incineration, landfill burial, and rendering for disposing of biological material potentially infected or contaminated with prion disease.
Similar articles
- Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.
Tal Y, Souan L, Cohen IR, Meiner Z, Taraboulos A, Mor F. Tal Y, et al. J Neurosci Res. 2003 Jan 15;71(2):286-90. doi: 10.1002/jnr.10474. J Neurosci Res. 2003. PMID: 12503092 - Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y, Yoshioka M, Yokoyama T, Iwamaru Y, Imamura M, Masujin K, Yoshiba S, Mohri S. Murayama Y, et al. Neurosci Lett. 2007 Feb 21;413(3):270-3. doi: 10.1016/j.neulet.2006.11.056. Epub 2006 Dec 14. Neurosci Lett. 2007. PMID: 17174030 - Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique.
Fujihara A, Atarashi R, Fuse T, Ubagai K, Nakagaki T, Yamaguchi N, Ishibashi D, Katamine S, Nishida N. Fujihara A, et al. FEBS J. 2009 May;276(10):2841-8. doi: 10.1111/j.1742-4658.2009.07007.x. FEBS J. 2009. PMID: 19459939 - Cell culture models to unravel prion protein function and aberrancies in prion diseases.
Bedecs K. Bedecs K. Methods Mol Biol. 2008;459:1-20. doi: 10.1007/978-1-59745-234-2_1. Methods Mol Biol. 2008. PMID: 18576144 Review. - Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases.
Sakaguchi S, Ishibashi D, Matsuda H. Sakaguchi S, et al. Expert Opin Ther Pat. 2009 Jul;19(7):907-17. doi: 10.1517/13543770902988530. Expert Opin Ther Pat. 2009. PMID: 19514955 Review.
Cited by
- Laboratory activities involving transmissible spongiform encephalopathy causing agents: risk assessment and biosafety recommendations in Belgium.
Leunda A, Van Vaerenbergh B, Baldo A, Roels S, Herman P. Leunda A, et al. Prion. 2013 Sep-Oct;7(5):420-33. doi: 10.4161/pri.26533. Epub 2013 Sep 20. Prion. 2013. PMID: 24055928 Free PMC article. Review. - Validation of an Autoclave Procedure for Sterilization of Mouse (Mus musculus) Carcasses.
Pils MC, Kränzler K, Beyer P, Heise U, Pasche B, Riedesel H. Pils MC, et al. J Am Assoc Lab Anim Sci. 2019 Jan 1;58(1):87-91. doi: 10.30802/AALAS-JAALAS-18-000020. Epub 2018 Nov 6. J Am Assoc Lab Anim Sci. 2019. PMID: 30401066 Free PMC article. - Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.
Volpicelli-Daley LA, Luk KC, Lee VM. Volpicelli-Daley LA, et al. Nat Protoc. 2014 Sep;9(9):2135-46. doi: 10.1038/nprot.2014.143. Epub 2014 Aug 14. Nat Protoc. 2014. PMID: 25122523 Free PMC article. - Validation of the Bio-Response Solutions Human-28 Low-Temperature Alkaline Hydrolysis System.
Denys GA. Denys GA. Appl Biosaf. 2019 Dec 1;24(4):182-188. doi: 10.1177/1535676019871389. Epub 2019 Dec 1. Appl Biosaf. 2019. PMID: 36032061 Free PMC article. - Treatment alternatives of slaughterhouse wastes, and their effect on the inactivation of different pathogens: a review.
Franke-Whittle IH, Insam H. Franke-Whittle IH, et al. Crit Rev Microbiol. 2013 May;39(2):139-51. doi: 10.3109/1040841X.2012.694410. Epub 2012 Jun 13. Crit Rev Microbiol. 2013. PMID: 22694189 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials